An observational study in Sickle Cell Disease, sponsored by Central Hospital, Nancy, France. Completed at 3 sites in France. Open to participants aged 0 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-11-09.
Sponsored by Central Hospital, Nancy, France · Observational
This retrospective observational multicenter study aims to describe the management of acute pain in children with sickle cell disease treated in the emergency departments of the University Hospitals of Nancy, Strasbourg, and Reims, France. The study analyzed routinely collected medical data from pediatric patients presenting with acute painful episodes related to sickle cell disease. Information regarding pain assessment, analgesic treatment, timing of care, and clinical outcomes was reviewed. No additional procedures or interventions were performed for the purpose of this study. All data were collected as part of standard clinical care. The results of this study may help improve the management of acute pain in children with sickle cell disease in emergency settings.
1,134 studies on the registry are indexed under Anemia, Sickle Cell; 238 are open to participants now.
This study's enrollment of 92 is close to the median of 100 across 296 observational studies indexed under Anemia, Sickle Cell.
Browse Anemia, Sickle Cell studies →Central Hospital, Nancy, France is the lead sponsor of 798 studies on the registry; 186 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Pediatric patients aged 0 to 17 years with confirmed sickle cell disease presenting to the emergency department for a painful vaso-occlusive crisis. The sudy includes patients from multiple hospitals and is based on retrospective review of medical records.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Time to first analgesic administration during vaso-occlusive crisis
Time (in minutes) between emergency department admission and administration of the first analgesic for vaso-occlusive crisis, as documented in the medical record
Time frame: During the index emergency department visit (up to 24 hours)
Type of analgesic treatment administered during vaso-occlusive crises
Type of analgesic treatment administered for vaso-occlusive crisis (World Health Organization (WHO) pain ladder levels I,II,III, and combinations), as documented in the medical record.
Time frame: During the index emergency department visit (up to 24 hours)
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Central Hospital, Nancy, France →